TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

BSS

CALCIUM CHLORIDE
Ophthalmology Approved 1997-12-10
Jump to: Indications Approvals Trials Competitors Safety Patents
1
Indication
--
Phase 3 Trials
28
Years on Market

Details

Status
Prescription
First Approved
1997-12-10
Routes
IRRIGATION
Dosage Forms
SOLUTION

Companies

Novartis
Active Ingredient: CALCIUM CHLORIDE , MAGNESIUM CHLORIDE , POTASSIUM CHLORIDE , SODIUM ACETATE , SODIUM CHLORIDE , SODIUM CITRATE

BSS Approval History

Loading approval history...

What BSS Treats

1 FDA approvals

Originally approved for its first indication in 1997 .

  • Other (1)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

BSS FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

: For use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA020742 → Label: DailyMed → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.